Transgenomic Inc Stock OTC Bulletin Board
Equities
TBIO
US89365K2069
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
||
- USD | - |
04-19 | Precipio, Inc. announced that it expects to receive $0.5 million in funding | CI |
04-01 | Transcript : Precipio, Inc. - Special Call |
Sales 2022 | 9.41M 12.81M | Sales 2023 | 15.2M 20.68M | Capitalization | 9.23M 12.56M |
---|---|---|---|---|---|
Net income 2022 | -12M -16.33M | Net income 2023 | -5M -6.8M | EV / Sales 2022 | 1.12 x |
Net cash position 2022 | 2.05M 2.79M | Net cash position 2023 | 386K 525K | EV / Sales 2023 | 0.58 x |
P/E ratio 2022 |
-1.03
x | P/E ratio 2023 |
-1.44
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 93.88% |
Latest transcript on Transgenomic Inc
Managers | Title | Age | Since |
---|---|---|---|
Ilan Danieli
CEO | Chief Executive Officer | 52 | 17-06-27 |
Matthew Gage
DFI | Director of Finance/CFO | 57 | 17-06-30 |
Ayman Mohamed
CTO | Chief Tech/Sci/R&D Officer | 39 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Ronald Andrews
BRD | Director/Board Member | 64 | 21-02-28 |
Kathy LaPorte
BRD | Director/Board Member | 62 | 18-08-08 |
Richard Sandberg
CHM | Chairman | 80 | 19-12-02 |
1st Jan change | Capi. | |
---|---|---|
-41.90% | 2.87B | |
+19.36% | 1.9B | |
-1.05% | 1.65B | |
+33.96% | 1.34B | |
-16.83% | 957M | |
-21.96% | 896M | |
+7.07% | 841M | |
-26.98% | 612M | |
+10.85% | 523M |
- Stock Market
- Equities
- PRPO Stock
- TBIO Stock